Literature DB >> 2842884

Isolation and washing of human platelets with nitric oxide.

M W Radomski1, R M Palmer, N G Read, S Moncada.   

Abstract

Nitric oxide (NO) was compared with prostacyclin as an inhibitor of the activation of human platelets during isolation, washing and storage. The use of NO throughout the procedure prevented the activation of platelets. The morphology and behaviour of NO-washed platelets was similar to that of prostacyclin-washed platelets when stored at 4 degrees C for up to 24 h. Prolonged storage resulted in deterioration of the platelets which occurred earlier in the NO-washed than in the prostacyclin-washed platelets. The protective effect of NO was potentiated by the selective cGMP phosphodiesterase inhibitor M & B 22948, suggesting that it is mediated by the activation of guanylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842884     DOI: 10.1016/0049-3848(88)90202-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.

Authors:  D Salvemini; G de Nucci; R J Gryglewski; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Acute anti-inflammatory activity and gastrointestinal tolerability of diclofenac and nitrofenac.

Authors:  A Conforti; M Donini; G Brocco; P Del Soldato; G Benoni; L Cuzzolin
Journal:  Agents Actions       Date:  1993-11

3.  Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.

Authors:  Stefan Chlopicki; Magdalena Lomnicka; Andrzej Fedorowicz; Elżbieta Grochal; Karol Kramkowski; Andrzej Mogielnicki; Włodzimierz Buczko; Roberto Motterlini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-25       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.